| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 124 |
| 1 | ETANERCEPT | 89 |
| 2 | LEFLUNOMIDE | 81 |
| 3 | METHOTREXATE SODIUM | 75 |
| 4 | TOCILIZUMAB | 74 |
| 5 | ABATACEPT | 73 |
| 6 | METHOTREXATE | 73 |
| 7 | PREDNISONE | 72 |
| 8 | HYDROXYCHLOROQUINE SULFATE | 62 |
| 9 | NAPROXEN SODIUM | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AUTOLOGOUS CULTURED CHONDROCYTES | 5 | 0.0111 |
| 1 | NAPROXEN SODIUM 220MG | 32 | 0.0023 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 5 | 0.0018 |
| 3 | ESTRADIOL CYPIONATE | 1 | 0.0017 |
| 4 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 5 | 0.0015 |
| 5 | ADALIMUMAB-FKJP | 58 | 0.0013 |
| 6 | ADALIMUMAB-AATY | 58 | 0.0012 |
| 7 | ADALIMUMAB-ADAZ | 58 | 0.0011 |
| 8 | ACETAMINOPHEN AND CODEINE | 11 | 0.0009 |
| 9 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 89 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 86 |
| 2 | Antirheumatic Agent [EPC] | 81 |
| 3 | Corticosteroid [EPC] | 77 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 74 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 73 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 73 |
| 7 | Vitamin D [EPC] | 61 |
| 8 | Vitamin C [EPC] | 58 |
| 9 | Vitamin B12 [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cultured Cell [EPC] | 5 | 0.0111 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 3 | Antirheumatic Agent [EPC] | 81 | 0.0008 |
| 4 | Interleukin-17A Antagonist [EPC] | 26 | 0.0007 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 74 | 0.0005 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 73 | 0.0005 |
| 7 | Ergot Derivative [EPC] | 2 | 0.0004 |
| 8 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |